Acorda Therapeutics Stocks List

Recent Signals

Date Stock Signal Type
2021-05-14 ACOR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 BIIB Upper Bollinger Band Walk Strength

Recent News for Acorda Therapeutics Stocks

Date Stock Title
May 14 BIIB Biogen (BIIB) Decides to Acquire Phase II Stroke Candidate
May 14 BIIB Biogen's Retinal Disease Gene Therapy Flunks Mid-Stage Study
May 14 BIIB UPDATE 1-Biogen's experimental eye treatment fails to meet study goal
May 14 BIIB Biogen's gene therapy fails to meet phase 2/3 eye disease main goal
May 14 BIIB Biogen Announces Topline Results From Phase 2/3 Gene Therapy Study for XLRP
May 13 BIIB Biogen, Envisagenics to collaborate on RNA splicing for CNS diseases
May 13 BIIB Biogen and Envisagenics Announce Collaboration to Advance RNA Splicing Research
May 13 BIIB The Zacks Analyst Blog Highlights: Regeneron, Moderna, Minerva Neurosciences, Amgen and Biogen
May 12 BIIB Biotech Stock Roundup: REGN's Q1 Earnings Update, MRNA's Vaccine Data & More
May 12 BIIB Biogen Buys Acute Ischemic Stroke Candidate For One-Time Payment Of $18M
May 12 BIIB Biogen (BIIB) Signs New Gene Therapy Deal for CNS Disorders
May 12 BIIB Biogen exercises option to buy stroke treatment from TMS
May 12 BIIB Biogen Announces Exercise of Option to Acquire the Investigational Drug TMS-007 for Acute Ischemic Stroke Based on Positive Phase 2a Data
May 12 BIIB Biogen, Cassava Sciences, And A Comparative Perspective On Treatment Of Alzheimer's Disease
May 11 BIIB Biogen, Capsigen Ink $1.3B AAV Capsids Development Pact For CNS & Neuromuscular Disorders
May 11 BIIB Biogen Collaborates With Capsigen To Develop New Gene Therapies
May 10 BIIB Biogen and Capsigen ink research collaboration agreement
May 10 BIIB Biogen and Capsigen Announce Collaboration to Discover and Develop Novel AAV Capsids for Targeted CNS and Neuromuscular Disorders
May 9 BIIB Some Prominent Doctors Continue to Shun Biogen's Alzheimer's Drug

Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York. The company develops therapies that improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.

More about Acorda Therapeutics
Browse All Tags